Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms.
Gut Microbes
; 15(2): 2249146, 2023 12.
Article
en En
| MEDLINE
| ID: mdl-37668317
ABSTRACT
Long-term sequelae of coronavirus disease (COVID)-19 are frequent and of major concern. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the host gut microbiota, which is linked to disease severity in patients with COVID-19. Here, we report that the gut microbiota of post-COVID subjects had a remarkable predominance of Enterobacteriaceae strains with an antibiotic-resistant phenotype compared to healthy controls. Additionally, short-chain fatty acid (SCFA) levels were reduced in feces. Fecal transplantation from post-COVID subjects to germ-free mice led to lung inflammation and worse outcomes during pulmonary infection by multidrug-resistant Klebsiella pneumoniae. transplanted mice also exhibited poor cognitive performance. Overall, we show prolonged impacts of SARS-CoV-2 infection on the gut microbiota that persist after subjects have cleared the virus. Together, these data demonstrate that the gut microbiota can directly contribute to post-COVID sequelae, suggesting that it may be a potential therapeutic target.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Microbioma Gastrointestinal
/
COVID-19
Tipo de estudio:
Diagnostic_studies
Límite:
Animals
Idioma:
En
Año:
2023
Tipo del documento:
Article